Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 4/20 | 0.42 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748722 | 0.84 | TTBK1 (0.38) | PRKDCALDH1A1MAPTSMN1; SMN2RAB9A | |
| SCHEMBL30748915 | 0.81 | ADORA3 (0.40) | PRKDCALDH1A1MAPTRAB9A | |
| SCHEMBL30749083 | 0.74 | ACACB (0.38) | ELANEALDH1A1MEN1KMT2A | |
| SCHEMBL30749132 | 0.74 | RAB9A (0.41) | ALDH1A1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL30748783 | 0.73 | AGXT (0.34) | RAD51ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL30748904 | 0.72 | RAD51 (0.42) | RAD51ALDH1A1SMN1; SMN2 | |
| SCHEMBL30748754 | 0.70 | XDH (0.36) | ALDH1A1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL30749140 | 0.68 | MAPT (0.39) | RAD51ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL5177701 | 0.68 | AR (0.55) | ALDH1A1MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL30748777 | 0.67 | PRKDC (0.39) | PRKDCRAD51ALDH1A1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| WO-2023241620-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2023-12-21 | — | — | WO | disclosed |